Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma Meeting Abstract

  


Authors: Abou-Alfa, G. K.; Johnson, P.; Knox, J.; Lacava, J.; Leung, T.; Mori, A.; Leberre, M. A.; Voliotis, D.; Saltz, L.
Abstract Title: Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma
Meeting Title: 14th European Cancer Conference (ECCO 14)
Journal Title: EJC Supplements
Volume: 5
Issue: 4
Meeting Dates: 2007 Sep 23-27
Meeting Location: Barcelona, Spain
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2007-09-01
Start Page: 259
Language: English
ACCESSION: WOS:000250204000854
DOI: 10.1016/s1359-6349(07)71003-0
PROVIDER: wos
Notes: --- - Meeting Abstract: 3500 - 14th European Cancer Conference (ECCO 14) - SEP 23-27, 2007 - Barcelona, SPAIN - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    791 Saltz
  2. Ghassan Abou-Alfa
    570 Abou-Alfa
Related MSK Work